Charumathi Sabanayagam1,2,3, WanFen Yip1, Daniel S W Ting1, Gavin Tan1, Tien Y Wong1,3,4. 1. a Singapore Eye Research Institute, Singapore National Eye Centre , Singapore. 2. b Center for Quantitative Medicine, Duke-NUS Medical School , Singapore. 3. c Yong Loo Lin School of Medicine , National University of Singapore , Singapore. 4. d Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School , Singapore.
Abstract
PURPOSE: Diabetes is a major public health problem affecting 415 million people worldwide. With the increasing prevalence of diabetes, diabetic retinopathy (DR) is emerging as the leading cause of avoidable blindness worldwide. METHODS: We reviewed previous and recent literature to provide an overview of emerging trends on the burden, epidemiology, risk factors, and prevention of DR. RESULTS: First, there is clear evidence of a global increase in the prevalence of diabetes. Second, there is a decline in the incidence of blindness due to DR, particularly in developed countries. Third, diabetic macular edema (DME) rather than proliferative diabetic retinopathy (PDR) is the increasingly common cause of visual impairment. Fourth, DR awareness remains patchy and low in most populations. Fifth, hyperglycemia remains the most consistent risk factor for DR in type 1 diabetes across different studies and populations. Sixth, in contrast, blood pressure is an important risk factor for DR in type 2 diabetes. Seventh, the relationship between dyslipidemia and DR remains unclear, with inconsistent results from different studies and trials. Eighth, the utility of predictive models incorporating multiple risk factors for assessing DR risk requires evaluation. Ninth, photographic screening of DR using tele-ophthalmology platforms is increasingly recognized as being feasible and cost-effective. Finally, DR prevention in low-resource settings cannot follow models developed in high-resource countries and requires different strategies. CONCLUSIONS: The ten trends we observed in the current review may guide planning of public healthcare strategies for the management of DR and prevention of blindness.
PURPOSE:Diabetes is a major public health problem affecting 415 million people worldwide. With the increasing prevalence of diabetes, diabetic retinopathy (DR) is emerging as the leading cause of avoidable blindness worldwide. METHODS: We reviewed previous and recent literature to provide an overview of emerging trends on the burden, epidemiology, risk factors, and prevention of DR. RESULTS: First, there is clear evidence of a global increase in the prevalence of diabetes. Second, there is a decline in the incidence of blindness due to DR, particularly in developed countries. Third, diabetic macular edema (DME) rather than proliferative diabetic retinopathy (PDR) is the increasingly common cause of visual impairment. Fourth, DR awareness remains patchy and low in most populations. Fifth, hyperglycemia remains the most consistent risk factor for DR in type 1 diabetes across different studies and populations. Sixth, in contrast, blood pressure is an important risk factor for DR in type 2 diabetes. Seventh, the relationship between dyslipidemia and DR remains unclear, with inconsistent results from different studies and trials. Eighth, the utility of predictive models incorporating multiple risk factors for assessing DR risk requires evaluation. Ninth, photographic screening of DR using tele-ophthalmology platforms is increasingly recognized as being feasible and cost-effective. Finally, DR prevention in low-resource settings cannot follow models developed in high-resource countries and requires different strategies. CONCLUSIONS: The ten trends we observed in the current review may guide planning of public healthcare strategies for the management of DR and prevention of blindness.
Authors: Spencer D Fuller; Jenny Hu; James C Liu; Ella Gibson; Martin Gregory; Jessica Kuo; Rithwick Rajagopal Journal: J Diabetes Sci Technol Date: 2020-10-30
Authors: Nicholas C Holoman; Jacob J Aiello; Timothy D Trobenter; Matthew J Tarchick; Michael R Kozlowski; Emily R Makowski; Darryl C De Vivo; Charandeep Singh; Jonathan E Sears; Ivy S Samuels Journal: J Neurosci Date: 2021-02-23 Impact factor: 6.167
Authors: Benedetta Maria Bonora; Mattia Albiero; Mario Luca Morieri; Roberta Cappellari; Francesco Ivan Amendolagine; Marta Mazzucato; Alberto Zambon; Elisabetta Iori; Angelo Avogaro; Gian Paolo Fadini Journal: Diabetologia Date: 2021-08-09 Impact factor: 10.122
Authors: Roberta Giordo; Yusra M A Ahmed; Hilda Allam; Salah Abusnana; Lucia Pappalardo; Gheyath K Nasrallah; Arduino Aleksander Mangoni; Gianfranco Pintus Journal: Front Cell Dev Biol Date: 2021-05-19
Authors: Linus G Jansen; Payal Shah; Bettina Wabbels; Frank G Holz; Robert P Finger; Maximilian W M Wintergerst Journal: Sci Rep Date: 2021-06-16 Impact factor: 4.379
Authors: Laima Brazionis; Anthony Keech; Christopher Ryan; Alex Brown; David O'Neal; John Boffa; Sven-Erik Bursell; Alicia Jenkins Journal: BMJ Open Ophthalmol Date: 2021-07-01